Top

Published in:

Open Access 01-12-2007 | Case report

Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report

Authors: Doron Todder, Bernhard T Baune

Published in: Journal of Medical Case Reports | Issue 1/2007

Abstract

This report describes a patient suffering from panic disorder who developed repeated suicidal ideation specifically due to the treatment with Venlafaxine. A first suicide attempt years ago occurred while being treated with Venlafaxine. Subsequent treatment with SSRIs or other antidepressants involved no suicidal ideation. Re-commencement of Venlafaxine four years later immediately led to a second suicide attempt. This unwanted effect subsided immediately after switching to another SNRI (i.e. Duloxetine). The case report underlines the importance of onset of suicide risk in panic disorders due to specific antidepressants.

Teicher MH, Glod C, Cole JO: Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry. 1990, 147 (2): 207-210.CrossRefPubMed

UK Medicines and Health Care Products Regulatory Agency, release. DH: Seroxat must not be used for treatment of children. 2003

Akiskal HS, Benazzi F: Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?. J Affect Disord. 2006, 94 (1-3): 105-110. 10.1016/j.jad.2006.04.002.CrossRefPubMed

Healy D: Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychother Psychosom. 2003, 72 (2): 71-79. 10.1159/000068691.CrossRefPubMed

APA: Diagnostic and Statistical Manual of Mental Disorders [4th ed] (DSM-IV). 1994

Simon GE, Savarino J, Operskalski B, Wang PS: Suicide risk during antidepressant treatment. Am J Psychiatry. 2006, 163 (1): 41-47. 10.1176/appi.ajp.163.1.41.CrossRefPubMed

Jick SS, Dean AD, Jick H: Antidepressants and suicide. Bmj. 1995, 310 (6974): 215-218.CrossRefPubMedPubMedCentral

Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B: Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. Bmj. 2005, 330 (7488): 396-10.1136/bmj.330.7488.396.CrossRefPubMedPubMedCentral

Isacsson G, Holmgren P, Ahlner J: Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides. Acta Psychiatr Scand. 2005, 111 (4): 286-290. 10.1111/j.1600-0447.2004.00504.x.CrossRefPubMed

10.

Gibbons RD, Hur K, Bhaumik DK, Mann JJ: The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry. 2005, 62 (2): 165-172. 10.1001/archpsyc.62.2.165.CrossRefPubMed

11.

Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ: Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007, 164 (9): 1356-1363. 10.1176/appi.ajp.2007.07030454.CrossRefPubMed

12.

Healy D, Langmaak C, Savage M: Suicide in the course of the treatment of depression. J Psychopharmacol. 1999, 13 (1): 94-99.CrossRefPubMed

13.

Healy D: The three faces of the antidepressants: a critical commentary on the clinical-economic context of diagnosis. J Nerv Ment Dis. 1999, 187 (3): 174-180. 10.1097/00005053-199903000-00007.CrossRefPubMed

14.

Akiskal HS, Benazzi F: Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized (bipolar) depressive mixed states?. Psychopathology. 2005, 38 (5): 273-280. 10.1159/000088445.CrossRefPubMed

15.

Rothschild AJ, Locke CA: Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. J Clin Psychiatry. 1991, 52 (12): 491-493.PubMed

16.

George DT, Anderson P, Nutt DJ, Linnoila M: Aggressive thoughts and behavior: another symptom of panic disorder?. Acta Psychiatr Scand. 1989, 79 (5): 500-502. 10.1111/j.1600-0447.1989.tb10294.x.CrossRefPubMed

17.

Celada P, Puig M, Amargos-Bosch M, Adell A, Artigas F: The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci. 2004, 29 (4): 252-265.PubMedPubMedCentral

18.

Adell A, Artigas F: Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn Schmiedebergs Arch Pharmacol. 1991, 343 (3): 237-244. 10.1007/BF00251121.CrossRefPubMed

19.

Bel N, Artigas F: Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol. 1992, 229 (1): 101-103. 10.1016/0014-2999(92)90292-C.CrossRefPubMed

20.

Invernizzi R, Belli S, Samanin R: Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 1992, 584 (1-2): 322-324. 10.1016/0006-8993(92)90914-U.CrossRefPubMed

21.

Blier P, de Montigny C: Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 1994, 15 (7): 220-226. 10.1016/0165-6147(94)90315-8.CrossRefPubMed

22.

Quinaux N, Scuvee-Moreau J, Dresse A: Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; correlation with reduction of spontaneous firing rate of central monoaminergic neurones. Naunyn Schmiedebergs Arch Pharmacol. 1982, 319 (1): 66-70. 10.1007/BF00491480.CrossRefPubMed

23.

Souery D, Oswald P, Linkowski P, Mendlewicz J: Molecular genetics in the analysis of suicide. Ann Med. 2003, 35 (3): 191-196. 10.1080/07853890310008242.CrossRefPubMed

24.

Flouri E: Psychological and sociological aspects of parenting and their relation to suicidal behavior. Arch Suicide Res. 2005, 9 (4): 373-383. 10.1080/13811110500182463.CrossRefPubMed

25.

Compton MT, Thompson NJ, Kaslow NJ: Social environment factors associated with suicide attempt among low-income African Americans: the protective role of family relationships and social support. Soc Psychiatry Psychiatr Epidemiol. 2005, 40 (3): 175-185. 10.1007/s00127-005-0865-6.CrossRefPubMed

Title: Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report
Authors: Doron Todder
Bernhard T Baune
Publication date: 01-12-2007
Publisher: BioMed Central
Published in: Journal of Medical Case Reports / Issue 1/2007
Electronic ISSN: 1752-1947
DOI: https://doi.org/10.1186/1752-1947-1-166

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2007

Gyrate atrophy of the choroid and retina with hyper-ornithinemia responsive to vitamin B6: a case report

Role of hemoclips in the management of acute bleeding from a gastric stromal tumor: a case report and review of the literature

Isolated radial head dislocation, a rare and easily missed injury in the presence of major distracting injuries: a case report

Neck fracture of a cementless forged titanium alloy femoral stem following total hip arthroplasty: a case report and review of the literature

Marathon related death due to brainstem herniation in rehydration-related hyponatraemia: a case report

Ventricular tachycardia after administration of sildenafil citrate: a case report